BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31631425)

  • 1. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
    Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
    Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.
    Rostam-Abadi Y; Rafiemanesh H; Gholami J; Shadloo B; Amin-Esmaeili M; Rahimi-Movaghar A
    Harm Reduct J; 2020 Oct; 17(1):81. PubMed ID: 33087141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.
    Rajabi A; Sharafi H; Alavian SM
    Harm Reduct J; 2021 Jan; 18(1):12. PubMed ID: 33482831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-time HIV testing among people who inject drugs in Iran: results from the National Rapid Assessment and Response survey.
    Roshanfekr P; Karimi SE; Narouee S; Moftakhar L; Vameghi M; Ali D; Higgs P; Soleimanvandiazar N
    Front Public Health; 2023; 11():1253407. PubMed ID: 37915820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.
    Blumenkrans E; Socías ME; Richardson L; Kerr T; Shoveller J; Montaner J; Milloy MJ
    AIDS Behav; 2020 Jul; 24(7):2163-2168. PubMed ID: 32026249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020.
    Khezri M; Shokoohi M; Mirzazadeh A; Tavakoli F; Ghalekhani N; Mousavian G; Mehmandoost S; Kazerooni PA; Haghdoost AA; Karamouzian M; Sharifi H
    AIDS Behav; 2022 Sep; 26(9):2831-2843. PubMed ID: 35195820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey.
    Khezri M; Karamouzian M; Sharifi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mehrabi F; Pedarzadeh M; Nejat M; Noroozi A; Baral S; Shokoohi M
    Int J Drug Policy; 2021 Nov; 97():103355. PubMed ID: 34242959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV prevalence, related risk behaviors, and correlates of HIV infection among people who use drugs in Cambodia.
    Sopheab H; Chhea C; Tuot S; Muir JA
    BMC Infect Dis; 2018 Nov; 18(1):562. PubMed ID: 30424727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
    Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
    Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran.
    Khezri M; Tavakoli F; Karamouzian M; Sharifi H; Ghalehkhani N; Mousavian G; Mehmandoost S; Bazargani M; Hosseinpour AM; Mahboubi M; Baral S; Shokoohi M
    J Subst Abuse Treat; 2022 Dec; 143():108868. PubMed ID: 36137306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
    Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
    Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis.
    Tran LT; Peacock A; Colledge S; Memedovic S; Grebely J; Leung J; Larney S; Trickey A; Stone J; Vickerman P; Hickman M; Degenhardt L
    Int J Drug Policy; 2020 Oct; 84():102866. PubMed ID: 32712484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV prevalence among non-injecting people who use drugs and related factors in Iran: A systematic review and meta-analysis.
    Gholami J; Rostam-Abadi Y; Rahimi Y; Fotouhi A; Amin-Esmaeili M; Rahimi-Movaghar A
    Drug Alcohol Rev; 2022 Mar; 41(3):666-676. PubMed ID: 34783411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.
    Khezri M; Goldmann E; Tavakoli F; Karamouzian M; Shokoohi M; Mehmandoost S; Ghalekhani N; Haghdoost AA; Des Jarlais D; Mirzazadeh A; Sharifi H
    Harm Reduct J; 2023 Oct; 20(1):145. PubMed ID: 37805505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV among people who inject drugs in India: a systematic review.
    Pachuau LN; Tannous C; Dhami MV; Agho KE
    BMC Public Health; 2022 Aug; 22(1):1529. PubMed ID: 35948967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis.
    Des Jarlais DC; Boltaev A; Feelemyer J; Bramson H; Arasteh K; Phillips BW; Hagan H
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S7-12. PubMed ID: 23891035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of latent tuberculosis infection and HIV among people who inject drugs in Iran.
    Radfar SR; Nematollahi P; Tayeri K; Dehghan H; Janani M; Higgs P; Mohsenifar S; Noroozi A
    Drug Alcohol Rev; 2021 May; 40(4):572-579. PubMed ID: 33345378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.